Shafique Virani's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 18,000 Class A Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on Jan. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 16 Jan 2024 | 18,000 | 154,748 | - | 2.2 | 39,960 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Virani Shafique | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 18,000 | 361,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.93 per share. | 16 Jan 2024 | 18,000 | 136,748 | - | 10.9 | 196,740 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.60 per share. | 15 Dec 2023 | 18,000 | 136,748 | - | 9.6 | 172,800 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Virani Shafique | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Dec 2023 | 18,000 | 154,748 | - | 2.2 | 39,960 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Virani Shafique | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 18,000 | 379,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 18,000 | 451,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.25 per share. | 15 Aug 2023 | 18,000 | 140,351 | - | 9.3 | 166,500 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Aug 2023 | 18,000 | 158,351 | - | 2.2 | 39,960 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 15 Aug 2023 | 3,603 | 140,351 | - | 9.2 | 33,112 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 25 Jul 2023 | 20,000 | 163,954 | - | 2.2 | 44,400 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.30 per share. | 25 Jul 2023 | 20,000 | 143,954 | - | 14.3 | 286,000 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 20,000 | 469,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 20,000 | 489,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.41 per share. | 25 Jul 2023 | 20,000 | 143,954 | - | 14.4 | 288,200 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 25 Jul 2023 | 20,000 | 163,954 | - | 2.2 | 44,400 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 17 Jul 2023 | 30,000 | 143,954 | - | 11.7 | 351,600 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 30,000 | 539,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.74 per share. | 17 Jul 2023 | 30,000 | 143,954 | - | 13.7 | 412,200 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 17 Jul 2023 | 30,000 | 173,954 | - | 2.2 | 66,600 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 17 Jul 2023 | 30,000 | 173,954 | - | 2.2 | 66,600 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 30,000 | 509,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Jun 2023 | 30,000 | 173,954 | - | 2.2 | 66,600 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 30,000 | 569,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 30,000 | 599,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 15 Jun 2023 | 30,000 | 143,954 | - | 9.4 | 282,300 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.67 per share. | 15 Jun 2023 | 30,000 | 143,954 | - | 9.7 | 290,100 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Jun 2023 | 30,000 | 173,954 | - | 2.2 | 66,600 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 01 Jun 2023 | 25,000 | 161,819 | - | 8.6 | 214,500 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.93 per share. | 01 Jun 2023 | 17,865 | 143,954 | - | 8.9 | 159,534 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 15 May 2023 | 2,230 | 185,102 | - | 5.6 | 12,488 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 7,486 | 629,469 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.33 per share. | 15 Feb 2023 | 7,486 | 189,846 | - | 8.3 | 62,358 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Feb 2023 | 7,486 | 197,332 | - | 2.2 | 16,619 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.42 per share. | 15 Feb 2023 | 1,768 | 187,332 | - | 8.4 | 14,887 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 15 Feb 2023 | 746 | 189,100 | - | 8.4 | 6,296 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 212,507 | 212,507 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 106,253 | 182,003 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 10,837 | 192,840 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.55 per share. | 01 Feb 2023 | 2,994 | 189,846 | - | 8.6 | 25,599 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.16 per share. | 17 Jan 2023 | 10,000 | 73,160 | - | 9.2 | 91,561 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 17 Jan 2023 | 5,000 | 83,160 | - | 2.2 | 11,100 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 5,000 | 636,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 15 Dec 2022 | 10,000 | 78,160 | - | 8.9 | 88,525 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Dec 2022 | 5,000 | 88,160 | - | 2.2 | 11,100 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 5,000 | 641,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 15 Nov 2022 | 5,059 | 88,101 | - | 12.7 | 64,249 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 5,000 | 646,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Nov 2022 | 5,000 | 93,160 | - | 2.2 | 11,100 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.92 per share. | 15 Nov 2022 | 4,941 | 83,160 | - | 11.9 | 58,873 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.86 per share. | 15 Nov 2022 | 613 | 88,160 | - | 11.9 | 7,270 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.21 per share. | 14 Oct 2022 | 5,000 | 93,773 | - | 11.2 | 56,050 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2022 | 5,000 | 651,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 14 Oct 2022 | 5,000 | 88,773 | - | 10.6 | 53,130 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 14 Oct 2022 | 5,000 | 98,773 | - | 2.2 | 11,100 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 15 Sep 2022 | 9,600 | 94,173 | - | 13.3 | 128,046 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Sep 2022 | 5,000 | 103,773 | - | 2.2 | 11,100 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 5,000 | 656,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.97 per share. | 15 Sep 2022 | 400 | 93,773 | - | 14.0 | 5,589 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 15 Aug 2022 | 30,000 | 98,773 | - | 12.6 | 378,444 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Aug 2022 | 25,000 | 128,773 | - | 2.2 | 55,500 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 25,000 | 661,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.96 per share. | 15 Aug 2022 | 613 | 103,773 | - | 13.0 | 7,944 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 16 May 2022 | 870 | 104,386 | - | 5.7 | 4,933 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 80,450 | 80,450 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 40,225 | 103,652 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 5,436 | 5,436 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,718 | 106,370 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. | 04 Feb 2022 | 1,114 | 105,256 | - | 11.4 | 12,700 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 45,045 | 686,955 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 02 Jun 2021 | 45,045 | 63,045 | - | 2.2 | 100,000 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | 20 Apr 2021 | 732,000 | 732,000 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | 20 Apr 2021 | 732,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Other type of transaction at price $ 0.00 per share. | 20 Apr 2021 | 18,000 | 0 | - | - | Common Stock | |
| Recursion Pharmaceuticals ... | Shafique Virani | Chief Corp. Dev. Officer | Other type of transaction at price $ 0.00 per share. | 20 Apr 2021 | 18,000 | 18,000 | - | - | Class A Common Stock |